This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Mark Boldiin: Innovator in Modulating Intracellular Pathways
Introduction
Mark Boldiin is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the modulation of intracellular inflammation and cell survival pathways. His work has implications for various medical applications, making him a key figure in his area of expertise.
Latest Patents
Mark Boldiin holds a patent for "Modulators of intracellular inflammation, cell death and cell survival pathways." This patent includes a B1 protein, its isoforms, analogs, fragments, and derivatives, along with the DNA encoding it and methods for recombinant production. The protein is particularly useful in modulating intracellular inflammation, cell death, and cell survival pathways, showcasing his innovative approach to addressing complex biological processes.
Career Highlights
Throughout his career, Mark has been associated with Yeda Research and Development Co. Ltd., where he has been able to apply his research in practical settings. His work has not only advanced scientific understanding but has also paved the way for potential therapeutic applications.
Collaborations
Mark has collaborated with esteemed colleagues such as Nikolai Malinin and David Wallach. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Mark Boldiin's contributions to the modulation of intracellular pathways highlight his role as a significant inventor in biotechnology. His patent and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.